存心
发表于 2025-3-23 10:33:36
http://reply.papertrans.cn/32/3190/318953/318953_11.png
CLAIM
发表于 2025-3-23 16:48:16
B Lymphocytes in Cancer Immunologyh and impair protective T-cell responses. Therefore, methods to eliminate autoreactive B cells, or switch them to a B effector-1 (Be-1) phenotype that amplifies Th1/Tc1-type T-cell responses, which are typically associated with effective antitumor responses, may improve the clinical outcomes of T-ce
辩论
发表于 2025-3-23 20:23:49
http://reply.papertrans.cn/32/3190/318953/318953_13.png
TOXIN
发表于 2025-3-23 22:32:08
http://reply.papertrans.cn/32/3190/318953/318953_14.png
愤世嫉俗者
发表于 2025-3-24 05:22:56
http://reply.papertrans.cn/32/3190/318953/318953_15.png
uveitis
发表于 2025-3-24 09:03:26
http://reply.papertrans.cn/32/3190/318953/318953_16.png
sacrum
发表于 2025-3-24 12:28:06
http://reply.papertrans.cn/32/3190/318953/318953_17.png
perjury
发表于 2025-3-24 16:17:45
Cytokine Immunotherapyne milieu, endogenous protection may be reestablished or even enhanced. It is therefore no surprise that cytokine immunotherapy holds great theoretical promise for the treatment of cancer. This theoretical promise has been borne out in a wide variety of preclinical models but unfortunately, clinical
坦白
发表于 2025-3-24 21:31:07
http://reply.papertrans.cn/32/3190/318953/318953_19.png
Fillet,Filet
发表于 2025-3-25 03:10:45
Genetically Engineered Antigen Specificity in T Cells for Adoptive Immunotherapyer of modified T cells over immunotherapies developed to date such as vaccines or cytokines alone is that T cells have the ability to directly traffic to the site of tumor or infection, to multiply at that site, and to persist in a memory state for months to years.